News Focus
News Focus
Replies to #84 on Seagen Inc (SGEN)
icon url

surf1944

09/13/10 8:27 AM

#85 RE: surf1944 #84

6:48AM Seattle Genetics: phase IIb clinical trial of lintuzumab in older patients with acute myeloid leukemia did not meet its primary endpoint of extending overall survival; co will discontinue its development program for lintuzuma (SGEN) 12.72 :